期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

法舒地尔对冠状动脉慢血流患者的作用

原文传递
导出
摘要 冠状动脉慢血流（coronary slow flow，CSF）是冠脉造影时管腔没有明显狭窄，但是血流缓慢，并且排除冠脉痉挛、冠脉扩张、结缔组织病、严重心脏瓣膜病等疾病的一种临床现象。冠脉慢血流患者虽然管腔未见狭窄，但是患者多可以伴有心绞痛、急性心肌梗死严重时可以猝死。
作者 李远 张童琪 王治乾 肖文良 魏玲格
机构地区 石家庄市第四医院心内科 唐山市工人医院肿瘤科 河北医科大学第三医院心内科 河北医科大学第三医院核医学科
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2014年第9期1033-1036,共4页 Chinese Journal of Emergency Medicine
关键词 冠状动脉 慢血流 患者 法舒地尔 急性心肌梗死 冠脉造影 结缔组织病 心脏瓣膜病
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding [J]. Am Heart J, 1972, 84 (1) : 66-71.
  • 2Erdogan D, Caliskan M, Gullu H, et al. Coronary flow reserve is impaired in patients with slow coronary flow [ J ]. Atherosclerosis, 2007, 191 (1): 168-174.
  • 3Cakmak M, Tanriverdi H, Cakmak N, et al. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow [J]. Cardiology, 2008, 110 (1): 39-44.
  • 4Signori LU, Quadros AS, Sbruzzi G, et al. Endothelial function in patients with slow coronary flow and normal coronary angiography [J]. Clinics (Sao Paulo), 2012, 67 (6) : 677-680.
  • 5Pries AR, Habazettl H, Ambrosio G, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings [J]. Cardiovasc Res, 20, 80 (2) : 165-174.
  • 6Li JJ, Nie SP, Qian XE, eta|. Elevated' plasma Creactive proteinand interleukin-6 levels in patients with slow coronary flow [ J ]. Clin Chim Acta, 2007, 385 (1/2) : 43-47.
  • 7郝春华,王维亭,赵专友,汤立达.法舒地尔对心脑血管疾病的药理作用及临床应用[J].现代药物与临床,2010,25(6):411-416. 被引量：26
  • 8Houghton BL, M eendering JR, Wong B J, et al. Nitric oxide and noradrenaline contribute to the temperature threshold of the axon reflex response to gradual local heating in human skin [ J ]. J Physiol, 2006, 572 (Pt3) : 811-820.
  • 9Hashimoto M, Gamoh S, Hossain S, et al. Agerelated changes in aortic sensitivity to noradrenaline and acetylcholine in rats [ J ]. Clin Exp Pharmacol Physiol, 1998, 25 (9) : 676-681.
  • 100 E, Ahn HY, Kim HK, et al. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures [J]. Int J Mol Med, 2011,28 (3) : 357-363.

二级参考文献47

  • 1Olson M F. Applications for ROCK kinase inhibition[J]. Curr Opin Cell Biol, 2008, 20 (2): 242-248.
  • 2Tybulewicz V L, Henderson R B. Rho family GTPases and their regulators in lymphocytes [J]. Nat Rev Immunol, 2009, 9 (9): 630-644.
  • 3PoppffM R, Geny B. Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins [J]. Biochim Biophys Acta, 2009, 1788 (4): 797-812.
  • 4Shi J, Wei L. Rho kinase in the regulation of cell death and survival [J]. Arch Immunol Ther Exp (Warsz), 2007, 55 (2): 61-75.
  • 5Burridge K, Wennerberg K. Rho and Rac take center stage [J]. Cell, 2004, 116 (2): 167-179.
  • 6Mueller B K, Mack H, Teusch N. Rho kinase a promising drug target for neurological disorders [J]. Nat Rev Drug Discov, 2005, 4 (5): 387-398.
  • 7Somlyo A P, Somlyo A V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II [J]. JPhysiol, 2010, 522 (2): 177-185.
  • 8Suematsu N, Satoh S, Kinugawa S, et al. Ladrenoceptor- Gq-RhoA signaling is upregulated to increase myofibrillar Ca^2+ sensitivity in failing heart [J]. Am J Physiol Heart Circ Physiol, 2001, 281 (2): 637-646.
  • 9Shah D I, Singh M. Involvement of Rho-kinase experimental vascular endothelial dysfunction [J]. Mol Cell Biochem, 2006, 283 (1/2): 191-199.
  • 10Nohria A, Grunert M E, Rikitake Y, et al. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease [J]. Circ Res, 2006, 99 ( 12): 1426-1432.

共引文献33

中华急诊医学杂志
2014年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部